Results 301 to 310 of about 3,117,334 (404)

Useful considerations for treating migraine in patients with autism

open access: yes
Headache: The Journal of Head and Face Pain, EarlyView.
Sinifunanya E. Nwaobi
wiley   +1 more source

Herpesvirus Simplex Virus‐1 Exploits Inflammation to Infect Periodontal Stem Cells and Disrupt Lineage Commitment

open access: yesJournal of Periodontal Research, EarlyView.
HSV‐1 infects oral mesenchymal stem cells both in vitro and in vivo to dysregulate their lineage commitment. An inflamed gingival environment increases susceptibility to HSV‐1 infection, which further elevates proinflammatory cytokine levels and exacerbates alveolar bone loss.
Araceli Valverde   +9 more
wiley   +1 more source

Reduced Frequency of Prolonged Sporadic Hemiplegic Migraine Attacks Following Fremanezumab Treatment-A Case Report. [PDF]

open access: yesEur J Neurol
Hotz JF   +9 more
europepmc   +1 more source

Migraine and Restless Legs Syndrome: A Meta‐Analysis

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Restless legs syndrome is a sensorimotor disorder of sleep/wake regulation that frequently coexists with migraine, affecting patients' quality of life. This study aimed to estimate the prevalence of restless legs syndrome in individuals with migraine and to explore the associated clinical, demographic and behavioural aspects.
Florindo d'Onofrio   +8 more
wiley   +1 more source

Moderate to Severe Acute Migraine Attacks: An Opinion Paper on the Use of Triptans and Triptan-NSAIDs Combinations in Individualized Treatment Plans. [PDF]

open access: yesNeurol Ther
Goadsby PJ   +14 more
europepmc   +1 more source

The Seven Works of Mercy; a 16th century Dutch picture gallery of skin disease

open access: yes
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Thomas M. van Gulik   +2 more
wiley   +1 more source

Valproic acid for treatment of traumatic brain injury: Study protocol for the VIBRANT prospective randomized trial

open access: yesTransfusion, EarlyView.
Abstract Background Traumatic brain injury (TBI) carries significant mortality and morbidity in civilian and military populations. Current treatment guidelines for TBI are primarily supportive, and no pharmacological agent exists to attenuate the progression of brain injury.
Maxime A. Visa   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy